Diabetic kidney disease in type 1 diabetes: challenges and differences from type 2 diabetes

Djordje S. Popovic, Dimitrios Patoulias, Luigi Gnudi, Christos S. Mantzoros*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

3 Citations (Scopus)
Original languageEnglish
Article number155763
JournalMetabolism: clinical and experimental
Volume151
DOIs
Publication statusPublished - Feb 2024

Keywords

  • Diabetic kidney disease
  • Finerenone
  • Glucagon-like peptide-1 receptor agonists
  • Sodium-glucose co-transporter 2 inhibitors
  • Type 1 diabetes

Cite this